Inventor · disambiguated record
Ta-Tung Yuan
Also filed as: YUAN TA TUNG
9 granted patents·7 pending applications·39 citations·filing 1997–2023
83Inventor score
Files withDEV CT BIOTECHNOLOGY4HUNILIFE BIOTECHNOLOGY INC4HSU YU-SHEN3DEV CENTER BIOTECHNOLOGY2SCHERING AG1
Top patents by PatentIndex Score
16 records- 0182US9382331B2Alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CENTER BIOTECHNOLOGY·Filed 2013·Granted Jul 5, 2016·5 cites·20 claims
- 0276US8110197B2Mutated E. coli heat-labile enterotoxinHSU YU-SHEN·Filed 2007·Granted Feb 7, 2012·2 cites·7 claims
- 0374US10781266B2Antibodies specific to alpha-enolase and uses thereofDEV CT BIOTECHNOLOGY·Filed 2018·Granted Sep 22, 2020·1 cites·10 claims
- 0471US9527922B2Humanized alpha-enolase specific antibodies and methods of uses in cancer therapyDEV CT BIOTECHNOLOGY·Filed 2014·Granted Dec 27, 2016·2 cites·15 claims
- 0568US8961971B2Bispecific T-cell activator antibodyDEV CENTER BIOTECHNOLOGY·Filed 2012·Granted Feb 24, 2015·2 cites·14 claims
- 0663US9750804B2Alpha-enolase specific antibodies and method of use in immune diseasesDEV CT BIOTECHNOLOGY·Filed 2014·Granted Sep 5, 2017·1 cites·15 claims
- 0762US5980901AViral defective interfering particles and uses thereofUNIV TEXAS·Filed 1997·Granted Nov 9, 1999·26 cites·9 claims
- 0859US2025034278A1Use of alpha-enolase antagonist for treating angiogenesis-related diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0956US2025243294A1Methods to regulate glycolysis via targeting extracellular alpha-enolase for treating human diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1056US2025075005A1Use of alpha-enolase antagonist in treating of fibrotic diseasesHUNILIFE BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 1155US8088394B2Mutated E. coli heat-labile enterotoxinHSU YU-SHEN·Filed 2008·Granted Jan 3, 2012·0 cites·6 claims
- 1251US2024207433A1Drug conjugates containing alpha-enolase antibodies and uses thereofHUNILIFE BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1342US2006188990A1Novel prostate tumor-specific promoterSCHERING AG·Filed 2003·Application pending·0 cites
- 1437US10624962B2Polysaccharide conjugation with detoxified E. coli heat labile enterotoxin (LT) used as vaccineHSU YU SHEN·Filed 2011·Granted Apr 21, 2020·0 cites·7 claims
- 1531US2017369525A1Site-specific conjugation through glycoproteins linkage and method thereofDEV CT BIOTECHNOLOGY·Filed 2015·Application pending·0 cites
- 1630US2011097302A1Il-1ra-polymer conjugatesYUAN TA TUNG·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →